Neurogene Inc. Annual Nonoperating Income (Expense) in USD from 2012 to 2022

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Neurogene Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2012 to 2022.
  • Neurogene Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2023 was $0.000.
  • Neurogene Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2023 was -$24K, a 36.8% increase year-over-year.
  • Neurogene Inc. annual Nonoperating Income (Expense) for 2022 was -$42K, a 223% decline from 2021.
  • Neurogene Inc. annual Nonoperating Income (Expense) for 2021 was -$13K, a 103% decline from 2020.
  • Neurogene Inc. annual Nonoperating Income (Expense) for 2020 was $451K, a 70.3% decline from 2019.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 -$42K -$29K -223% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-20
2021 -$13K -$464K -103% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-20
2020 $451K -$1.07M -70.3% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-01
2019 $1.52M +$478K +46% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-25
2018 $1.04M +$103K +11% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-12
2017 $936K +$293K +45.6% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-12
2016 $643K +$1.16M Jan 1, 2016 Dec 31, 2016 10-K 2019-03-07
2015 -$520K +$1.13M +68.5% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-12
2014 -$1.65M -$2.29M -357% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-09
2013 $642K +$633K +6944% Jan 1, 2013 Dec 31, 2013 10-K 2016-03-14
2012 $9.11K Jan 1, 2012 Dec 31, 2012 10-K 2015-03-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.